D-Alanine is a structural component of mycobacterial peptidoglycan. The primary route of Dalanine biosynthesis in eubacteria is the enantiomeric conversion from L-alanine, a reaction catalysed by D-alanine racemase (Alr). Mycobacterium smegmatis alr insertion mutants are not dependent on D-alanine for growth and display a metabolic pattern consistent with an alternative pathway for D-alanine biosynthesis. In this study, we demonstrate that the M. smegmatis alr insertion mutant TAM23 can synthesize D-alanine at lower levels than the parental strain. The insertional inactivation of the alr gene also decreases the intracellular survival of mutant strains within primary human monocyte-derived macrophages. By complementation studies, we confirmed that the impairment of alr gene function is responsible for this reduced survival. Inhibition of superoxide anion and nitric oxide formation in macrophages suppresses the differential survival. In contrast, for bacteria grown in broth, both strains had approximately the same susceptibility to hydrogen peroxide, acidified sodium nitrite, low pH and polymyxin B. In contrast, TAM23 exhibited increased resistance to lysozyme. D-Alanine supplementation considerably increased TAM23 viability in nutritionally deficient media and within macrophages. These results suggest that nutrient deprivation in phagocytic cells combined with killing mediated by reactive intermediates underlies the decreased survival of alr mutants. This knowledge may be valuable in the construction of mycobacterial auxotrophic vaccine candidates.
INTRODUCTION
Mycobacteria display complex cell walls consisting of glycolipids and proteins linked to the mycolyl-arabinogalactan-peptidoglycan backbone (Brennan & Nikaido, 1995; McNeil & Brennan, 1991) . This structure is a major determinant of mycobacterial drug resistance and pathogenesis (Daffé & Draper, 1998; Trias & Benz, 1994) , and its biosynthesis is highly conserved among different mycobacterial species (Belanger & Inamine, 2000) . Intracellular survival is an essential determinant of mycobacterial pathogenesis. To survive within phagocytic cells, mycobacteria must overcome the bactericidal mechanisms of macrophages, including reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI) and lysosomal enzymes (Armstrong & Hart, 1975; Lowrie & Andrew, 1988; Sturgill-Koszycki et al., 1994 status also plays a role in the intracellular survival of mycobacteria within macrophages (De Voss et al., 2000; Hondalus et al., 2000; Jackson et al., 1999) .
Mycobacterium smegmatis, a fast-growing species of low pathogenicity, displays a basal but measurable level of resistance to macrophage killing. Studies with this microorganism have been conducted using a diverse array of macrophages (Jordao et al., 2008) , including murine (Anes et al., 2006; Kuehnel et al., 2001 ) and human (McGarvey et al., 2004; Miller & Shinnick, 2000) cell lines, and tissuederived macrophages of murine (Kocincova et al., 2009; Singh et al., 2008; Wagner et al., 2005) or human origin (Garg et al., 2006; Lagier et al., 1998) . M. smegmatis interaction with mouse phagocytic cells results in generation of ROI and RNI, including nitric oxide (Anes et al., 2006) . In vitro susceptibility of M. smegmatis to RNI is well documented (Yu et al., 1999) . In addition, expression of Mycobacterium tuberculosis genes in M. smegmatis alters its resistance to macrophage killing, and this effect has been widely used in the identification of mycobacterial genes involved in intracellular survival of pathogenic mycobacteria (Miller & Shinnick, 2000; Singh et al., 2008) . Since M. smegmatis has a high-efficiency genetic transfer system and fast growth, it has been used as an affordable model to study mycobacterial physiology, including the effects of metabolic changes on intracellular survival, gene expression and regulation, and this is especially meaningful for the study of highly conserved pathways (Caceres et al., 1997; Danilchanka et al., 2008; Garg et al., 2006; Glover et al., 2007; Lagier et al., 1998; Posey et al., 2006; Provvedi et al., 2008) .
D-Alanine is a structural component of mycobacterial peptidoglycan (Strominger, 1962) . D-Alanine racemase catalyses the primary route of D-alanine biosynthesis in mycobacteria (Chacon et al., 2002) . D-Alanine is also present in the core head group of glycopeptidolipids (GPLs) of many mycobacterial species, with Mycobacterium xenopi illustrating the only exception among those species analyzed (Brennan & Nikaido, 1995; Eckstein et al., 2003; Etienne et al., 2005; Riviere & Puzo, 1991) . Genetic analysis of the D-alanine branch of peptidoglycan biosynthesis in mycobacteria was first carried out in M. smegmatis, which possesses, as does M. tuberculosis, only one alr gene (Caceres et al., 1997; Cole et al., 1998) . We have demonstrated that D-alanine racemase insertion mutants (alr) are not dependent on D-alanine for growth (Chacon et al., 2002) . These mutants also exhibit increased susceptibility to the bactericidal agent D-cycloserine (DCS), a D-alanine analogue used as a second-line drug in tuberculosis treatment. We hypothesized that disrupting D-alanine biosynthesis would also impair survival in macrophages, as a result of modifications in the cell envelope and/or nutrient deprivation in phagocytic cells. In this study we determine the levels of D-alanine biosynthesis and the survival of M. smegmatis parental and alr mutant strains under various extracellular conditions and in human monocyte-derived macrophages.
METHODS
Bacterial strains, plasmid vectors and growth conditions.
Bacterial strains and vectors used in this study have been previously described (Chacon et al., 2002) . Escherichia coli DH5a was grown as described elsewhere (Sambrook et al., 1989) . M. smegmatis parental strain mc 2 155 (Snapper et al., 1990) , its derived alr mutant TAM23 (Chacon et al., 2002) , and their transformants with the integrating vectors pYUB178 (Pascopella et al., 1994) , pYUB412 (Pavelka & Jacobs, 1999) and pTAMU3 (Chacon et al., 2002) , were grown at 37 uC with shaking (200 r.p.m. with an Innova 4300, New Brunswick Scientific) to OD 600~1 .0. Supplements for complete Middlebrook 7H9 (BBL Microbiology Systems) medium were 0.2 % (v/v) glycerol (Sigma-Aldrich), 0.05 % Tween 80 (Sigma-Aldrich) to prevent clumping, 0.01 % cycloheximide (A.G. Scientific) to prevent fungal contamination, and ADC [0.5 % bovine fraction V albumin (Amresco), 0.01 M glucose (Acros), and 0.015 M NaCl (MADC-TW)]. Broth minimal medium was prepared as previously described (Chacon et al., 2002) . Generation times were determined as described elsewhere (Miller, 1972) . c.f.u. were estimated from optical density measurements using appropriate calibration curves. In addition, M. smegmatis c.f.u. were determined after incubation at 37 uC on MADC agar (Tween 80 was omitted from all solid media) or appropriately supplemented 7H9 basal medium prepared with 15 g Bacto agar l
21
(Difco Laboratories). D-Alanine (Sigma-Aldrich) was added at 50 mM as necessary to broth cultures and agar plates.
Analysis of amino acid intracellular pools. Steady-state levels of intracellular amino acid pools were determined as previously described (Feng & Barletta, 2003) . M. smegmatis strains mc 2 155 and TAM23 were grown in 250 ml minimal medium with 21 mM glycerol (carbon source) and 5 mM NH 4 Cl (nitrogen source) to exponential phase (OD 600 0.5-0.9), treated for 2 h with or without DCS at 75 mg ml
, harvested, washed and sonicated to prepare cell-free proteinfree extracts as previously described (Chacon et al., 2002) . Protein was removed from the supernatant by serial passages through YM-10 and YM-3 Centricon concentrators (Millipore Corporation). Determination of amino acids was performed at the Amino Acid Geochronology Laboratory of Northern Arizona University (Flagstaff, AZ) by a reverse-phase HPLC procedure as described elsewhere (Kaufman & Manley, 1998) . This procedure was able to detect nine pairs of L-and D-amino acids in the subpicomolar range based on the derivatization reaction of amino acids with o-phthaldialdehyde (OPA) and the chiral compound N-isobutyryl-L-cysteine. The synthetic amino acid L-homo-arginine (L-hArg) was spiked in the samples at 10 mM as an internal standard. The total amount of amino acids in the recovered pools was averaged for each strain/treatment combination and expressed as micromoles total OPA-derivatized product per 1610 9 cells. Relative abundance percentiles of individual amino acids were calculated as a molar percentage of the total pool for each sample.
Intracellular killing assays. Intracellular killing assays were carried out as described previously, with some modifications (Bermudez & Young, 1988) . Prior to infection, M. smegmatis cells were grown in MADC-TW with and without D-alanine to OD~1.0, harvested, and resuspended in Hanks' Balanced Salts Solution (HBSS; SigmaAldrich). Cells were passed through a membrane filter (1.2 mm pore-size, Millipore) to obtain a single-cell suspension, and sedimented for 5 min at room temperature. Macrophages were infected with 1.0 ml supernatant appropriately diluted in HBSS. 5 per well) derived from blood of healthy human donors were seeded in tissue-culture plates (Sigma-Aldrich) and incubated for 2 h at 37 uC in 5 % CO 2 . Procedures for blood collections were performed in compliance with all federal and local regulations. Supernatant fluids with non-adherent cells were removed and the wells were washed twice with 1.0 ml prewarmed HBSS. The IP: 54.70.40.11
On: Wed, 09 Jan 2019 21:36:13 adherent monocytes were maintained in culture for 7 days with 1.5 ml complete RPMI 1640 (Invitrogen) medium supplemented with 2 mM L-glutamine (Sigma-Aldrich) and 10 % heat-inactivated fetal bovine serum (Sigma-Aldrich), and D-alanine where indicated; the medium was replaced every 48 h. Macrophage monolayers were infected at an m.o.i. of 1 or 10 bacilli per cell, as indicated. Monolayers were incubated for 1-2 h at 37 uC in 5 % CO 2 followed by three washes with HBSS to remove extracellular micro-organisms. Similar washes were performed at each time point. An m.o.i. of 1 bacillus per cell was used as necessary to maximize the effects of host cell restriction on bacterial growth. For inhibitor treatment assays, cells were split 30 min post-infection and supplemented as indicated with bovine superoxide dismutase (SOD; Sigma-Aldrich), human catalase (Sigma-Aldrich), or the nitric oxide (NO) synthase inhibitor N-methyl-L-arginine (NM-L-Arg; SigmaAldrich) following previously described procedures (Bermudez & Young, 1989; Bermudez, 1993) . Cells were lysed at 1 or 2, 24, 48 (except inhibitor assays) and 72 h with 0.5 ml sterile double-distilled H 2 O (ddH 2 O) for 10 min and 0.025 % SDS (Sigma-Aldrich) in HBSS for another 10 min. SDS was subsequently removed with 0.1 % bovine albumin and the lysate was plated on MADC. Three replicate wells were used per experimental group, in at least two independent experiments.
Cell viability was determined by trypan blue exclusion as previously described (Bermudez & Young, 1988) . The viability of the cell monolayer post-infection decreased slightly from 98-99 % (1 h) to 90-92 % (24 h), 84-86 % (48 h) and 73-77 % (72 h). No significant differences were observed at each time point in the viability of macrophage monolayers subjected to different treatments or infected with various strains. To verify that the addition of SDS did not detrimentally affect the viability of the M. smegmatis parental and alr mutant strains,~5.0610 6 c.f.u. were treated with ddH 2 O for 10 min and 0.025 % SDS for 10 min, and 0.1 % albumin was added. Bacteria were plated to determine c.f.u. There were no significant differences for the titre of either mc 2 155 (P50.7662) or TAM23 (P50.6901) strains before and after treatment, or between mc 2 155 and TAM23 (P50.9422) in their susceptibility to SDS. Another experiment using 20 mg amikacin ml 21 (Sigma-Aldrich) during invasion yielded similar results, demonstrating the effectiveness of the washing procedure for removing extracellular bacteria (data not shown).
Susceptibility assays. Susceptibility assays with M. smegmatis cells grown in MADC-TW were carried out at different treatment agent levels (hydrogen peroxide, lysozyme and polymyxin B sulfate) or the kinetics of killing was followed at a standardized level of the agent (sodium nitrite, hydrochloric acid and lysozyme). The effect of hydrogen peroxide (H 2 O 2 ) on the viability of M. smegmatis was determined as described elsewhere (Yu et al., 1998) . Cell cultures were grown with or without D-alanine, harvested, washed with PBS-Tween 80 (PBS-TW), resuspended in the same volume of PBS-TW, and treated with 0-30 mM H 2 O 2 (Sigma-Aldrich) in 5 mM increments. Cells were incubated for 30 min at 37 uC, washed with MADC-TW, and plated on MADC supplemented with D-alanine. To determine the effects of lysozyme, cells were plated on MADC with 0, 500, 750 and 1000 mg ml 21 of hen egg-white lysozyme (Sigma-Aldrich). To determine the susceptibility to the model antimicrobial cationic peptide polymyxin B (sulfate salt, Invitrogen), bacteria were plated on MADC with 0, 16, 32, 64 and 96 mg ml 21 of this antimicrobial peptide.
Sodium nitrite (NaNO 2 ) susceptibility was determined as previously described (Firmani & Riley, 2002) , with modifications. Cell aliquots (0.5 ml) were adjusted to~1.0610 6 c.f.u. ml 21 and added to MADC-TW at pH 4.0 or 6.5 adjusted with HCl and 0, 2, 4 or 6 mM NaNO 2 (Sigma-Aldrich). Samples were collected at 0, 2, 5 and 24 h posttreatment. For susceptibility to HCl alone, 0.5 ml cell aliquots (adjusted to~1.0610 8 c.f.u. ml 21 ) were combined with MADC-TW at pH 4.0 adjusted with HCl. Samples were taken at 0, 7, 12, 24, 48, 72 and 96 h after treatment. To follow the kinetics of lysozyme, cells were grown in MADC-TW with or without 500 mg lysozyme ml 21 . Samples were collected at 0, 3, 6, 12 and 24 h post-treatment and washed with MADC-TW. In all cases, c.f.u. were determined on MADC agar.
MICs were determined by a previously described microdilution method (Chacon et al., 2002) . Two compounds were tested: imipenem (compound MK0787, US Pharmacopeia), a b-lactam transpeptidase inhibitor with broad-spectrum anti-microbial activity (Kesado et al., 1980) ; and vancomycin (Sigma-Aldrich), a glycopeptide that binds to D-alanyl-D-alanine moieties (Perkins & Nieto, 1974) . Briefly, cells were grown in MADC-TW to mid-exponential phase (OD 600 0.6-1.0), adjusted to~1.0610 5 c.f.u. in 0.1 ml, and inoculated into 96-well microplates containing serial twofold dilutions of the corresponding antimicrobial agent. The MIC was defined as the minimal drug concentration that prevented visible bacterial growth at 37 uC after 48 h.
Effects of nutritional supplements on M. smegmatis growth.
Strains mc
2 155 and TAM23 were grown in MADC-TW without and with D-alanine, respectively. Bacteria were washed twice with PBS-TW, resuspended in the original volume of PBS-TW, and plated on 7H9 basal agar without and with supplementation with 0.15 % (v/v) glycerol; 50 mM D-alanine; 0.5 % (w/v) albumin; 10 mM glucose; albumin, glucose and D-alanine; or glycerol, ADC and D-Alanine (MADC+D-alanine).
Statistical and graphical analysis. Statistical analyses were performed using SAS version 9.1.3, 2004 (SAS Institute). Logtransformed c.f.u. were analysed as a repeated measure design and included the effects for strain and treatment, and their interaction. The repeated measures analyses were carried out using the Mixed procedure. The covariance structure for each analysis was selected based on the Schwarz's Bayesian Criterion. Post-hoc comparisons for the amino acid analysis were carried out using Tukey adjusted P values; for the nutritional supplement analysis, Bonferroni adjusted P values were used. The Cluster procedure was used to determine the average linkage distance (joins clusters with small variances) between strains grouped together. For the H 2 O 2 , lysozyme and polymyxin B analyses, LD 50 values were estimated for each strain replicate combination using the Probit procedure. These LD 50 values were then analysed as a one-way ANOVA. Contrast and estimate statements were used to determine the statistical significance for line graphs. Bar and line graphs were constructed using DeltaGraph version 5.6.2 (Red Rock Software). Fig. S1b ). However, the yield was higher with D-alanine than in its absence, as OD 600 values were 2.6 and 1.4, respectively. In addition, growth in the absence of D-alanine was characterized by a lag time of 30±4 h that did not occur with D-alanine. Complementation of TAM23 with the integrating vector pTAMU3, which carries the wild-type alr gene, restored parental properties. The generation times of TAM23 (pTAMU3) in the presence and absence, of Dalanine were 210±30 and 180±25 min, respectively. More importantly, this recombinant strain grew in the absence of D-alanine without a lag time ( Supplementary Fig. S1c ), reaching OD 600 3.0, similar to the wild-type strain. As expected in the presence of D-alanine, TAM23(pTAMU3) reached a lower OD 600 value of 2.1. Growth patterns were also determined in nutrient-restricted minimal medium with glycerol (sole carbon source) and ammonium chloride (sole nitrogen source). Similar results were obtained for the parental and complemented strains, but TAM23 grew with longer generation and lag times in the absence of D-alanine ( Supplementary Fig. S2 ). A second passage of TAM23 without D-alanine resulted in a growth pattern similar to that of mc 2 155, displaying no lag time (Chacon et al., 2002) .
RESULTS

Biosynthesis of D-alanine in an M. smegmatis alr insertion mutant
The D-alanine-independent phenotype of M. smegmatis alr insertion mutants suggests that M. smegmatis possesses an alternative pathway of D-alanine biosynthesis (Chacon et al., 2002; Halouska et al., 2007) . Alternatively, this microorganism may be able to synthesize peptidoglycan and other essential components without D-alanine. To distinguish between these two alternative hypotheses, we determined whether the mutant strain could synthesize D-alanine.
Strains mc 2 155, mc 2 155 treated with the Alr inhibitor DCS, and TAM23 synthesized approximately the same level of total amino acids, as quantified by OPA (Fig. 1, inset) . This result demonstrates that bacteria do not compensate for the alr mutation by making more of all amino acids. However, significant changes in their relative abundance were observed (Fig. 1) . When compared with untreated mc 2 155, mc 2 155 with DCS (P50.0061) and TAM23 (P50.0005) yielded a 14 and 25 % decrease in the highly abundant Lglutamate-L-glutamine (L-Glx) pool, respectively. This result is consistent with the decrease in the overall glutamate pool observed in our TAM23 metabolomic analysis (Halouska et al., 2007) . Significant increases were observed in the Lalanine (L-Ala) pools for TAM23 (about 4.5-fold, P,0.0001) and mc 2 155 with DCS (about 1.7-fold, P50.0003) compared to mc 2 155. A decreasing trend was detected in the Dalanine (D-Ala) pools upon treatment with DCS or in TAM23. These results further confirm our metabolomic studies, but the current analysis shows that the total increase in the alanine pools is determined by higher levels of the Lenantiomer. Though not significant at the P,0.05 level, similar trends were seen for the total
In all cases, mc 2 155 with DCS followed the same trend as TAM23, but TAM23 displayed the most extreme values, as expected from the complete inactivation of the alr gene, in contrast to the DCS inhibition of Alr enzyme activity. Importantly, the internal D-Ala pools, although approximately 3.5-fold less than those of mc 2 155, were above background levels. Thus, inhibition of the Alr enzyme by DCS or impairment of alr gene function has a significant influence on alanine metabolism, leading to a decrease in the D-Ala pool and an accumulation of L-Ala. The L-Ala: DAla ratio was 1.7 : 1 for mc 2 155, 10 : 1 for mc 2 155 with DCS, and 28 : 1 for TAM23.
M. smegmatis alr mutants display impaired survival in human macrophages
Since alr insertion mutants displayed poor growth in media without D-alanine, we hypothesized that D-alanine limitation would also lead to decreased intracellular survival in the nutrient-limiting macrophage environment. To max- imize potential differences, macrophage monolayers were infected with bacilli grown in medium without D-alanine.
The uptake levels at 2 h post-infection for both parental and mutant strains were similar (Fig. 2) . As expected, mc 2 155 displayed moderate survival in macrophages, while TAM23 survived very poorly (P,0.0001). The complemented strain TAM23 (pTAMU3) displayed similar survival levels at 48 h (P50.3867) and 72 h (P50.2473) compared with mc 2 155. This result confirmed that the inactivation of the alr gene is responsible for the reduced intracellular survival of TAM23.
In addition, we tested the effects of selection markers on the survival of M. smegmatis in phagocytic cells (Fig. 2) . Strain mc 2 155 (pYUB178), which carries the kanamycinresistance marker used to inactivate the alr gene, displayed a survival trend similar to that of the parental strain at 48 h (P50.3475), indicating that this marker does not affect the intracellular survival of M. smegmatis. Strain mc 2 155 (pYUB412), which carries the hygromycin-resistance complementing vector, displayed an increase in intracellular survival at all time points as compared with TAM23 (P,0.0001). At 24 h post-infection, TAM23 (pYUB412) displayed a similar fivefold reduction in intracellular survival as seen for TAM23; however, at 48 and 72 h, TAM23 (pYUB412) displayed an intermediate level of survival when compared with mc 2 155 and TAM23. Thus, the hygromycin-resistance marker influences intracellular survival at longer times post-infection. Nonetheless, the effect is different from the complete recovery of TAM23 survival conferred, at every time point post-infection, by the hygromycin-resistance integrating vector pTAMU3 carrying the wild-type alr gene. In summary, global analysis of survival data indicated that each strain displayed a unique survival curve (P,0.0001). However, cluster analysis grouped mc 2 155, TAM23 (pTAMU3) and mc 2 155 (pYUB178) together with a normalized root mean square distance (NRMSD) of 0.27. This cluster was separated from the TAM23 (pYUB412) (NRMSD50.73) and TAM23 (NRMSD51.43) clusters. Thus, the inactivation of the alr gene has a significant effect on the ability of M. smegmatis to survive within phagocytic cells (P,0.0001).
Susceptibility of M. smegmatis to bactericidal agents
Experiments were performed to further define the susceptibilities of wild-type and alr mutant strains to agents that mediate or enhance intracellular bactericidal action in macrophages. Susceptibilities to reactive intermediates were first assessed on bacteria grown in broth by determining the effects of H 2 O 2 and acidified NaNO 2 . As shown in Supplementary Fig. S3(a) , no significant differences were observed in the susceptibilities to H 2 O 2 (P50.0544) of mc Fig. S3b ).
Susceptibilities to ROI and RNI within macrophages were also tested using inhibitors (Fig. 3) . Treatment of monolayers with the H 2 O 2 -detoxifying enzyme catalase did not result in significant differences for mc 2 155 (P50.1544) or TAM23 (P50.6225) as compared with the corresponding untreated controls, while major differences were observed between strains (P50.0002). Scavenging of superoxide anion with SOD led to significant differences for TAM23 (P,0.0001) as compared with the untreated control, while a minor effect was observed for mc 2 155 (P50.1316 comparing all time points, P50.0158 at 72 h). However, no significant differences were observed between strains upon SOD treatment (P50.6116). Inhibition of NO synthase with NM-L-Arg resulted in a significant increase in the survival of mc 2 155 (P50.0238) and TAM23 (P,0.0001) as compared with the corresponding untreated controls, with no difference between the strains (P50.9171), indicating that production of reactive intermediates plays an important role in differential killing.
Upon phagolysosomal fusion, mycobacteria may be exposed to acid pH, lysosomal enzymes and cationic peptides. Exposure of mc 2 155 and TAM23 to pH 4.0 (without NaNO 2 ) for 24 h did not result in significant differences ( Supplementary Fig. S3b ). Furthermore, extending the pH treatment to 96 h yielded the same outcome (data not shown). The potential effects of the alr mutation on the peptidoglycan structure may result in altered susceptibility to lysozyme and polymyxin B. Treatment with 500 or 750 mg lysozyme ml 21 decreased survival of mc 2 155 (~95 %) and TAM23 (~85 %) (P50.0344), with a more pronounced effect (~98 % for both strains) at 1000 mg lysozyme ml 21 (Fig. 4a ). Significant differences were observed in the susceptibilities to lysozyme of mc 2 155 (LD 50 47 mg ml
21
) and TAM23 (LD 50 205 mg ml 21 ). To confirm these results, the bactericidal action of 500 mg lysozyme ml 21 was also followed in MADC-TW 24 h post-treatment (Fig. 4b) . The survival dropped 500-(TAM23) to 4500-fold (mc 2 155), indicating that lysozyme has a greater bactericidal action on the parental strain (P,0.0001), although the survival curves follow similar trends. Thus, the changes in TAM23 appear to make its peptidoglycan less susceptible to lysozyme. In contrast, TAM23 was slightly more susceptible to polymyxin B than mc 2 155 (Fig. 4c) , although this trend did not reach statistical significance (P50.0660).
We have reported the hypersusceptibility of TAM23 to DCS with an MIC of 2.56 mg ml
, as compared with 75 mg ml 21 for mc 2 155, while the susceptibilities to amikacin, ethambutol and ribafutin remain at parental levels (Chacon et al., 2002) . In this study, the MICs against two additional drugs related to peptidoglycan structure were determined. Mutant TAM23 was significantly more susceptible to imipenem (MIC 0.625 versus 20 mg ml 21 ) and vancomycin (MIC 1.56 versus 12.5 mg ml
). These 
Effect of nutritional supplements on M. smegmatis growth
Macrophages restrict nutrients to phagocytosed bacteria, an effect that has been termed a nutriprive mechanism (Appelberg, 2006) . This restriction may include essential ions (Wagner et al., 2005) , purines, pyrimidines, amino acids and vitamins. To test the effects of nutritional supplementation, parental and mutant cells were plated on various solid media. As shown in Table 1, significant  differences were found between mc   2 155 and TAM23 on 7H9 basal medium and 7H9 supplemented with glycerol or D-alanine. No significant differences were observed for the remaining supplementations. Comparing the growth performance of each strain individually in the various media, both strains performed best and equally well on basal agar with albumin, glucose and D-alanine; and MADC plus D-alanine (P51.00). Intermediate growth was observed for both strains with the addition of glycerol, D-alanine, albumin or glucose to the basal medium. Basal agar yielded the poorest growth for both strains with a more prominent effect on TAM23. These observations confirmed that alr insertional mutants grow better with Dalanine, but are not dependent on this nutrient.
To test for the effect of D-alanine in macrophages, parental and mutant strains were grown in MADC with or without D-alanine prior to the infection of monolayers cultured without D-alanine. The uptake of mc 2 155 and TAM23 by monolayers of adherent human macrophages 1 h postinfection was similar, regardless of D-alanine supplementation (Fig. 5a ). As expected, mc 2 155 grown in broth with or without D-alanine displayed similar survival in macrophages (P50.309), but TAM23 survived better when grown in broth with D-alanine (P,0.0001). As described above (Fig. 2) , mc 2 155 survived better than TAM23 (P,0.0001, for all pairwise comparisons). A similar effect was obtained when TAM23 was grown without D-alanine and macrophage monolayers were incubated with or without Dalanine during the course of the infection (Fig. 5b) . In the absence of D-alanine, TAM23 was less able to survive as compared with conditions in which monolayers were supplemented with D-alanine (P50.0166). In summary, the difference in the viability of both strains in basal media reflected the intracellular survival data well.
DISCUSSION
The goal of this study was to analyse the physiological consequences of the insertional inactivation of the alr gene in M. smegmatis in the context of both extracellular and intracellular survival. We have shown that alr insertion mutants are not dependent on D-alanine for growth, and display changes in colony morphology, metabolomic profiling and hypersusceptibility to DCS (Chacon et al., 2002; Halouska et al., 2007) . We hypothesized that alr mutants synthesize D-alanine by an alternative pathway. In contrast, another study indicates that M. smegmatis alr deletion mutants are auxotrophic for D-alanine (Milligan et al., 2007) . However, there are significant differences in the experimental design that led to mutant isolation and characterization in the two studies, including a two-step procedure and shorter follow-up incubation in the study of the alr deletion mutants. Furthermore, metabolomic analysis of the TAM23 alr insertion mutant indicates metabolic changes more readily compatible with the activation of an alternative pathway of D-alanine biosynthesis (Halouska et al., 2007) . Thus, the differences between these two studies may reflect changes in the experimental conditions.
In this study, the analysis of the amino acid pools indicates that the TAM23 alr mutant exhibits lower, but above background, levels of D-alanine and L-glutamate and accumulation of L-alanine, as compared with the parental strain. These results are consistent with our hypothesis and previous studies (Chacon et al., 2002; Halouska et al., 2007) . As expected, the effect of alr insertional inactivation on these amino acid pools is more pronounced than the effect of DCS, an Alr inhibitor. Thus, insertional inactivation of the alr gene in TAM23 results in markedly reduced availability of D-alanine (indicated by a low D-alanine pool in the mutant), possibly leading to decreased incorporation of this amino acid into peptidoglycan and glycolipids. Structural analyses will be conducted to test this hypothesis.
The insertional inactivation of the M. smegmatis alr gene resulted in 80 % reduction in the intracellular survival of the mutant strain in monocyte-derived human macrophages at 24 h post-infection (Fig. 2) . This effect is considerably more pronounced than the 20-50 % reduc- D-alanine) were grown at 37 uC in MADC-TW to OD 600 1.0, washed twice in PBS-TW, and plated on solid media (SEM50.056, n53). DBonferroni adjustment (significant at P,0.007).
tion observed for other M. smegmatis mutants under similar conditions (Lagier et al., 1998) . The conservation of basic metabolic pathways in mycobacteria plus the effect of alr mutation on extracellular and intracellular survival of M. smegmatis would predict a considerable degree of attenuation for alr mutant strains of pathogenic mycobacterial species, provided viable mutants could be obtained.
Pathogenic mycobacteria have greater ability to evade bactericidal mechanisms such as phagosome acidification, while M. smegmatis fails to prevent this process (SturgillKoszycki et al., 1994) . However, intracellular bacilli of both M. smegmatis and pathogenic mycobacterial species are exposed to killing by reactive intermediates (Anes et al., 2006; Jordao et al., 2008; , though controversial results have been obtained (Ehrt et al., 1997) . In our case, extracellular treatment with H 2 O 2 , NaNO 2 and acidic pH had a bactericidal action on M. smegmatis, but did not reveal any major survival differences between the strains. H 2 O 2 scavenging by catalase treatment of infected monolayers had no effect on the viability of any of the strains as compared with untreated controls. However, scavenging of superoxide anion by SOD or inhibition of NO synthase by the specific inhibitor NM-L-Arg resulted in decreased bactericidal activities in macrophage monolayers. This effect was more pronounced in the alr mutant. This suggests that in our experimental conditions, reactive intermediates have an important role in M. smegmatis killing by human macrophages, as indicated in Fig. 3 . Since RNI inhibition may not affect superoxide anion production by the phagocyte oxidase pathway, it is possible that SOD scavenging of superoxide only limits its conversion to peroxynitrite, a highly bactericidal product formed from superoxide and NO. In contrast, other studies have failed to detect reactive intermediates and conclude that these molecules do not have a major role in M. smegmatis killing by human monocytes (Jordao et al., 2008) . However, these molecules are difficult to detect, given their short life and low concentrations in the macrophages (Forman & Torres, 2001; Valko et al., 2007) .
The results presented herein suggest that the use of inhibitors is a more reliable indicator of the involvement of reactive intermediates than the failure to detect relatively low levels of these molecules by the Griess reaction. This situation is particularly critical in our study, since the human monocytes were not activated with c-interferon. Nonetheless, infection with M. smegmatis (Ehrt et al., 1997) , maturation in culture (Martin & Edwards, 1993) , and specific experimental conditions may sufficiently increase reactive intermediate levels, especially for RNI, to have bactericidal action on this micro-organism, as suggested by our inhibition studies. Activation of the arginase pathway reduces arginine availability for the NO synthase reaction in murine macrophages (Martin et al., 2006) . This leads to an increase in intracellular levels of Lglutamate. A similar effect might be possible upon NO synthase inhibition by NM-L-Arg. Since L-glutamate seems to be involved in the alternative pathway of D-alanine biosynthesis in M. smegmatis alr mutants, this effect could increase the survival of the mutant strain to wild-type levels in the absence of D-alanine (Fig. 5) . The differential microbicidal effect on TAM23 in untreated macrophages may also reflect the increased permeability of the mutant strain to reactive intermediates. In either case, preloading of TAM23 cells with D-alanine or its addition to monolayers had a partially compensatory effect (Fig. 5) . Thus, the effects of nutrient deprivation in phagocytic cells combined with killing mediated by reactive intermediates determined the differential survival of the strains. The decreased pool of D-alanine might also result in a further reduction in the GPL content of TAM23, affecting both colony morphology and susceptibility to macrophage killing (Kocincova et al., 2009) .
Additional bactericidal mechanisms operate in lysosomal compartments. In this context, we observed a slight decrease rather than an increased susceptibility to lysozyme, an enzyme that hydrolyses the longitudinal peptidoglycan strands. This effect may be due to subtle changes in the peptidoglycan layer. However, a weakened cell wall structure was suggested by an increased susceptibility to DCS (Chacon et al., 2002) , imipenem, polymyxin B and vancomycin. These findings are consistent with peptidoglycan alterations as a result of the downshift in the Dalanine pool.
Auxotrophic mutations decrease the intracellular survival of pathogenic micro-organisms, including mycobacteria (Appelberg, 2006; Crawford et al., 1996; Guleria et al., 1996; Mintz et al., 1988) . This effect may be related to the reduced availability of nutrients in the phagosome, in contrast to the relatively rich cytoplasmic compartment. In the case of mycobacteria, the vacuole is deficient in purines, amino acids, vitamins and other nutrients (Brown et al., 2005; Hondalus et al., 2000; Jackson et al., 1999; Pavelka et al., 2003) . Our studies suggest a combined effect of nutrient deficiency and reactive intermediate molecules on the intracellular survival of mycobacteria inside nutrient-deficient vacuoles. Inhibition of ROI and/or RNI may also result in metabolic changes in the phagosome that could alter the attenuation of auxotrophic mutant strains. Mutants absolutely dependent on D-alanine for growth would likely autolyse in vivo, providing potentially safer auxotrophic vaccines. If the alr gene is essential in M. tuberculosis, as suggested by global genomic analysis (Sassetti et al., 2003) , it may still be possible to engineer viable mutants by introducing the M. smegmatis alternative pathway genes under the control of a regulated promoter. Thus, these studies are significant for the development of novel live attenuated vaccines to control mycobacterial diseases.
